CDKN1A and breast cancer: In our experiments we tested the effect of NS1643 on p21 in several breast cancer cells lines including those in which mutations in the p53 gene rendered p53 non-functional (T47D; SKBr3; MDA-MB-231) or in cells in which was wild p53 was expressed (MCF7).